Up to 10% of patients with breast cancer have a hereditary predisposition to cancer. However, the assessment needed to determine which patients meet criteria for genetic testing is time-consuming and complicated, with many breast cancer patients never getting assessed. Insurance coverage for genetic testing depends on such an assessment. Valid and scalable approaches are needed to assist non-genetics clinicians in assessing whether a patient meets criteria for genetic testing

RISE Risk Assessment Module: Hereditary Cancer is a brief patient-administered digital tool that has been clinically validated for assessing if patients meet criteria for genetic testing and may assist in getting insurance covered testing for those that qualify.